image class="left" url="http://media2.picsearch.com/is?r5czrHM_sVlj7XbVqhuMItqd3neJ8PKLTAIruEWFSME&height=198"Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, like the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to do so may be grounds for compensation. Our lawyers are working tough to acquire those hurt by the drug the compensation they may be entitled to.













Whilst bleeding is actually a frequent complication connected with anticoagulants, it has been alleged that Xarelto is more harmful than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This implies that, inside the event of an emergency, sufferers may possibly be at danger for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.













Should you or even a loved one suffered a significant bleeding event after taking Xarelto, you might have legal recourse. For more details, contact us these days to have your case reviewed, free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in instances of death, funeral costs. Additionally, they may be looking for punitive damages, that are normally awarded to punish the defendant and deter other firms from acting similarly.






Why Are Lawsuits Being Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of just click the up coming site drug continue to market Xarelto as a protected anticoagulant option.






Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.






Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.













Visit this page for far more info on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki